Success Metrics

Clinical Success Rate
81.5%

Based on 53 completed trials

Completion Rate
82%(53/65)
Active Trials
7(7%)
Results Posted
19%(10 trials)
Terminated
12(12%)

Phase Distribution

Ph phase_2
21
21%
Ph phase_1
24
24%
Ph phase_3
6
6%
Ph phase_4
13
13%
Ph early_phase_1
3
3%
Ph not_applicable
29
29%

Phase Distribution

27

Early Stage

21

Mid Stage

19

Late Stage

Phase Distribution96 total trials
Early Phase 1First-in-human
3(3.1%)
Phase 1Safety & dosage
24(25.0%)
Phase 2Efficacy & side effects
21(21.9%)
Phase 3Large-scale testing
6(6.3%)
Phase 4Post-market surveillance
13(13.5%)
N/ANon-phased studies
29(30.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.7%

53 of 70 finished

Non-Completion Rate

24.3%

17 ended early

Currently Active

7

trials recruiting

Total Trials

100

all time

Status Distribution
Active(12)
Completed(53)
Terminated(17)
Other(18)

Detailed Status

Completed53
unknown16
Terminated12
Withdrawn5
Not yet recruiting4
Recruiting4

Development Timeline

Analytics

Development Status

Total Trials
100
Active
7
Success Rate
81.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.1%)
Phase 124 (25.0%)
Phase 221 (21.9%)
Phase 36 (6.3%)
Phase 413 (13.5%)
N/A29 (30.2%)

Trials by Status

enrolling_by_invitation11%
suspended22%
not_yet_recruiting44%
unknown1616%
completed5353%
withdrawn55%
terminated1212%
recruiting44%
active_not_recruiting33%

Recent Activity

Clinical Trials (100)

Showing 20 of 100 trialsScroll for more
NCT07729579Phase 1

An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face

Recruiting
NCT03576105Not Applicable

Evaluation of Photodynamic Therapy in Pericoronitis

Completed
NCT04429308Phase 2

PDT vs Peels for Treatment of Actinic Keratoses

Not Yet Recruiting
NCT06381154Phase 2

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Active Not Recruiting
NCT06307548Phase 1

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Recruiting
NCT06437288Phase 4

Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

Enrolling By Invitation
NCT03678350Phase 1

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Completed
NCT04836429Phase 1

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

Terminated
NCT02153229Phase 2

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Active Not Recruiting
NCT07254260

Photodynamic Therapy and Post-Endodontic Pain in Undergraduate-Performed Treatments

Completed
NCT07179003Phase 2

A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses

Not Yet Recruiting
NCT03033225Phase 2

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Completed
NCT06752343Phase 2

A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study

Completed
NCT06712381Phase 1

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Completed
NCT03467789Phase 1

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Completed
NCT04618276Not Applicable

Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-II)

Completed
NCT06445699Not Applicable

Photodynamic Therapy With Hydrogel Dressing for Chronic Wounds

Recruiting
NCT06523244Not Applicable

Comparing Photodisinfection of Chitosan NP Enriched ICG Over ICG as Adjunct to OFD: RCT

Not Yet Recruiting
NCT06485050Not Applicable

Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes.

Active Not Recruiting
NCT00930189Phase 2

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Withdrawn

Drug Details

Intervention Type
DEVICE
Total Trials
100